-
SpiceJet, PLUSS sign MoU for COVID-19 vaccine delivery
expresspharma
December 29, 2020
PLUSS to supply indigenously developed precise temperature control boxes to maintain efficacy of the vaccine.
-
Effective effluent management: Key to tackle AMR
expresspharma
December 29, 2020
As the world adjusts to the post-COVID-19 reality, it is time to reflect and reset. It cannot be ‘business as usual’ in the struggle to survive.
-
FDA accepts Hepion’s IND application for CRV431 to treat Covid-19
pharmaceutical-business-review
December 28, 2020
The US Food and Drug Administration (FDA) has accepted Hepion Pharmaceuticals’ investigational new drug (IND) application for its CRV431, a novel cyclophilin inhibitor, to treat Covid-19.
-
Beckman Coulter Launches High-Throughput COVID-19 Antigen Test
americanpharmaceuticalreview
December 28, 2020
Beckman Coulter announced the launch of a new test that addresses the three main barriers currently facing schools, businesses, hospitals and communities with the rollout of mass COVID-19 testing.
-
ADEXUSDx COVID-19 Antibody Test Filed for EUA Confirmed 100% Accurate with BEI Panel
americanpharmaceuticalreview
December 28, 2020
NOWDiagnostics has announced study results for its ADEXUSDx? COVID-19 antibody test yielded encouraging test performance—providing a strong use case for the innovative diagnostic device, which was filed for Emergency Use Authorization (EUA) from ...
-
M&As in bio/pharma industry high despite COVID-19: GlobalData
expresspharma
December 28, 2020
Down only 13 per cent compared with last year, with a total deal value of $228 billion compared with $262 billion in 2020, and almost twice the 2017 total deal value of $126 billion.
-
Study finds antibodies target different parts of SARS-CoV-2 in severe COVID-19 cases
expresspharma
December 28, 2020
People with severe COVID-19 have lower levels of antibodies targeting the spike protein used by the virus to enter human cells than those targeting proteins of the inner shell of the SARS-CoV-2 virus.
-
Europe rolls out vaccines against COVID-19
expresspharma
December 28, 2020
The region has secured contracts with a range of suppliers for over two billion vaccine doses and has set a goal for all adults to be inoculated during 2021.
-
Serbia begins COVID-19 vaccination drive, with PM first in line
expresspharma
December 25, 2020
Serbia is the third country in Europe to start mass COVID-19 inoculations after Britain and Switzerland.
-
Vicore Pharma’s C21 med shows promise in COVID-19 study
pharmatimes
December 24, 2020
Vicore Pharma’s lead candidate drug C21 has scored some promising results in a study evaluating the medicine in hospitalised COVID-19 patients.